100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached 4.2 TrustPilot
logo-home
Summary

Samenvatting Rookstop, Salhi, Revalidatie en kinesitherapie van het respiratoire stelsel

Rating
-
Sold
-
Pages
24
Uploaded on
25-05-2023
Written in
2022/2023

Een samenvatting van de theorieles van B. Salhi van het vak revalidatie en kinesitherapie van het respiratoire stelsel. Alle info uit de les + lesnotities

Institution
Course










Whoops! We can’t load your doc right now. Try again or contact support.

Written for

Institution
Study
Course

Document information

Uploaded on
May 25, 2023
Number of pages
24
Written in
2022/2023
Type
Summary

Subjects

Content preview

Rookstop
Inleiding
 Dalende trend in het gebruik van tabak




o
 Rokers in België
o 24 % rookt (23% : EU /wereld)
o 19 % rookt dagelijks (23% wereld)
o Dagelijks gemiddeld 14 sigaretten/dag. (14 sig/d EU)
o Mannen roken meer dan vrouwen
o 64 % van de rokers rookt gewone sigaretten en 36% van hen rookt roltabak. (78% vs.
28% EU)
 Roltabak stijgt omdat sigaretten steeds duurder worden
o 62% van de rokers wil stoppen met roken, maar 21% wil een poging ondernemen
binnen de 6 maand.
 Roken begint vaak op jonge leeftijd
o Factors associated with youth tobacco use include:
 Low socioeconomic status
 Smoking by peers / siblings
 Smoking by parents or guardians
 Perception that smoking is the norm
 => het zien roken zet aan tot roken
 Het aantal rokers stijgt tot mid-life
o The average number of cigarettes smoked per day increases with age into the mid-
40s, reducing slightly above 55 years of age




o
 bij eerste klachten beseffen ze dat ze moeten stoppen (rond 40jaar)
 Roken
o > 4000 chemicals
o > 150 carcinogenic
o The two primary carcinogens in tobacco smoke are polycyclic aromatic hydrocarbons
(PAHs) and nitrosamines, known as nicotine derived nitrosamine ketone (NNK).
 CO→ betere affiniteit om zich te binden op Hb
 hoe meer sigaretten rookt , hoe hoger de concentratie

,  => minder zuurstof in circulatie aanwezig
 Tar
 teer => ontstaat bij verbranden tabak
 Nicotine
 Alkaloid
 Belangrijkste psychoactieve substantie
o reden waarom men blijft roken
 Primair niet kankerverwekkend
o secundair wel, apoptose vertragen, werkt immunosuppresief
 Stimuleert autonoom en CZS
 Blokkeert insuline
o vermageren, eetlust remmend effect

, Gevolgen van roken
 roken = slecht voor alles elk orgaan aantasten




 Gevolgen op pulmonair systeem
o 1secondewaarde gaat afnemen=> onder 1L => lastig in dagelijks leven (moeite met
aankleden, ...
o vatbare roker: lijn gaat heel snel naar beneden
o stoppen voor 30e is zeer belangrijk
 stopt met roken => lijn terug dichter bij fysiologische lijn
$3.59
Get access to the full document:

100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached


Also available in package deal

Get to know the seller

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
zafiekine Universiteit Gent
Follow You need to be logged in order to follow users or courses
Sold
69
Member since
4 year
Number of followers
38
Documents
27
Last sold
1 month ago

3.6

11 reviews

5
2
4
4
3
4
2
1
1
0

Recently viewed by you

Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Frequently asked questions